Barbara J. van Zwieten

Medicines Evaluation Board — Netherlands

Medicine · Health Sciences

12h-index534citations18works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Treatment of Major Depression(8), Schizophrenia research and treatment(6), Bipolar Disorder and Treatment(5), Pain Management and Placebo Effect(5), Mental Health and Psychiatry(4)

Publications18 total

Magnitude of effect of lithium in short‐term efficacy studies of moderate to severe manic episode
Bipolar Disorders·2007· 48 cited
Suicide risk in placebo-controlled trials of bipolar disorder - Dr Storosum and colleagues reply
Data Archiving and Networked Services (DANS)·2006
Suicide Risk in Placebo-Controlled Trials of Bipolar Disorder
2006
Antidepressants use in children and adolescents and the risk of suicide
European Neuropsychopharmacology·2005· 72 cited
Suicide Risk in Placebo-Controlled Trials of Treatment for Acute Manic Episode and Prevention of Manic-Depressive Episode
American Journal of Psychiatry·2005· 24 cited
Response to Tricyclic Antidepressants: Independent of Gender?
American Journal of Psychiatry·2004· 52 cited
Natural Course and Placebo Response in Short-Term, Placebo-Controlled Studies in Major Depression: A Meta-Analysis of Published and Non-published Studies
Pharmacopsychiatry·2004· 18 cited
How real are patients in placebo-controlled studies of acute manic episode?
European Neuropsychopharmacology·2003· 18 cited
Suicide Risk in Placebo vs Active Treatment in Placebo-Controlled Trials for Schizophrenia
Archives of General Psychiatry·2003· 39 cited
Heroine en methadon op medisch voorschrift voor chronisch, therapieresistente heroineverslaafden: twee gerandomiseerde studies
Data Archiving and Networked Services (DANS)·2003
El tratamiento con heroína es una alternativa válida en el tratamiento de los pacientes drogodependientes
FMC - Formación Médica Continuada en Atención Primaria·2003
Dr. Storosum and Colleagues Reply
American Journal of Psychiatry·2002· 1 cited
Amisulpride: Is There a Treatment for Negative Symptoms in Schizophrenia Patients?
Schizophrenia Bulletin·2002· 33 citedOpen Access
Relapse and recurrence prevention in major depression: a critical review of placebo-controlled efficacy studies with special emphasis on methodological issues
European Psychiatry·2001· 22 cited
Erratum to “Short-term efficacy of tricyclic antidepressants revisited: a meta-analytic study”
European Neuropsychopharmacology·2001
Suicide Risk in Placebo-Controlled Studies of Major Depression
American Journal of Psychiatry·2001· 113 cited
Short-term efficacy of tricyclic antidepressants revisited: a meta-analytic study
European Neuropsychopharmacology·2001· 74 cited
Schizophrenia: Do we really need placebo-controlled studies?
European Neuropsychopharmacology·1998· 20 cited

Frequent Co-authors

Jitschak G. Storosum(11), Wim van den Brink(9), Berthold P. R. Gersons(6), Tamar Wohlfarth(6), André Elferink(5), J.G. Storosum(5), André W. Broekmans(4), Christine C. Gispen‐de Wied(4), R. van Strik(3), A.J.A. Elferink(3), Don Linszen(3), W van den Brink(3), Annemarie Fouwels(2), T. Wohlfarth(2), W. van den Brink(2), Vincent M. Hendriks(2), Peter Blanken(2), Maarten W.J. Koeter(2), Frits J.F. Lekkerkerker(1), Jerry R. Ruis(1)